Overview of Protease Inhibitors-Reference-Cited by-同舟云学术

Overview of Protease Inhibitors

Published:1997-09 Issue:5 Volume:37 Page:543-551
ISSN:1086-5802
Container-title:Journal of the American Pharmaceutical Association (1996)
language:en
Short-container-title:Journal of the American Pharmaceutical Association (1996)

Author:

Pakyz Amy,Israel Debra

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference37 articles.

1. Update: trends in AIDS incidence, deaths, and prevalence—United States;MMWR,1996

2. Update: mortality attributable to HIV infection among persons aged 25-44 years—United States;MMWR,1994

3. Therapy for human immunodeficiency virus infection;Hirsch;N Engl J Med.,1993

4. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents;U.S. Department of Health,1997

5. Reports of diabetes and hyperglycemia in patients receiving protease inhibitors for the treatment of human immunodeficiency virus (HIV);Public Health Advisory,1997

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A prospective study to estimate the incidence and pattern of adverse drug reactions to first-line antiretroviral therapy (tenofovir, efavirenz, and lamivudine);Indian Journal of Sexually Transmitted Diseases and AIDS;2023

2. Inhibition of Plasmodium falciparum cysteine protease falcipain-2 by a human cross-class inhibitor serpinB3: A mechanistic insight;Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics;2019-09

3. Inhibitory Effects of Some Traditional Medicines on Proliferation of HIV-1 and Its Protease;YAKUGAKU ZASSHI;2004-08-01

4. Epidural Lipomatosis Secondary to Indinavir in an HIV-Positive Patient;Clinical Neuropharmacology;2002-01

5. Hyperlipidemia and inhibitors of HIV protease;Current Opinion in Clinical Nutrition and Metabolic Care;2001-03